Andreas Moosmann

2.9k total citations
54 papers, 2.1k citations indexed

About

Andreas Moosmann is a scholar working on Epidemiology, Immunology and Oncology. According to data from OpenAlex, Andreas Moosmann has authored 54 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 27 papers in Immunology and 22 papers in Oncology. Recurrent topics in Andreas Moosmann's work include Cytomegalovirus and herpesvirus research (27 papers), Immune Cell Function and Interaction (23 papers) and Viral-associated cancers and disorders (16 papers). Andreas Moosmann is often cited by papers focused on Cytomegalovirus and herpesvirus research (27 papers), Immune Cell Function and Interaction (23 papers) and Viral-associated cancers and disorders (16 papers). Andreas Moosmann collaborates with scholars based in Germany, United States and United Kingdom. Andreas Moosmann's co-authors include Wolfgang Hammerschmidt, Reinhard Zeidler, Josef Mautner, Simon Jochum, Nicole Walz, Sebastian Grömminger, Eri Seto, Adam Grundhoff, Stephan Lang and Uta Behrends and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Andreas Moosmann

54 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Moosmann Germany 24 1.3k 1.0k 830 378 302 54 2.1k
Dai Iwakiri Japan 19 955 0.7× 698 0.7× 454 0.5× 578 1.5× 309 1.0× 26 1.8k
Claire Shannon‐Lowe United Kingdom 27 1.7k 1.3× 830 0.8× 696 0.8× 348 0.9× 791 2.6× 36 2.3k
Kathrin Zitzmann Germany 15 613 0.5× 855 0.9× 518 0.6× 347 0.9× 160 0.5× 24 1.6k
Ken‐Ichi Imadome Japan 22 859 0.7× 606 0.6× 330 0.4× 188 0.5× 409 1.4× 103 1.4k
Jianmin Zuo United Kingdom 25 1.1k 0.8× 972 1.0× 749 0.9× 220 0.6× 288 1.0× 69 2.0k
Nancy Gudgeon United Kingdom 16 869 0.7× 1.4k 1.4× 791 1.0× 178 0.5× 234 0.8× 23 1.9k
Thomas Duhen United States 19 931 0.7× 2.3k 2.3× 249 0.3× 342 0.9× 201 0.7× 34 2.9k
Heather M. Long United Kingdom 24 1.2k 1.0× 902 0.9× 596 0.7× 173 0.5× 553 1.8× 37 1.8k
Misako Yajima Japan 15 566 0.4× 458 0.5× 365 0.4× 210 0.6× 223 0.7× 25 1.1k
Jacqueline M. Burrows Australia 26 734 0.6× 1.4k 1.3× 542 0.7× 294 0.8× 344 1.1× 36 2.0k

Countries citing papers authored by Andreas Moosmann

Since Specialization
Citations

This map shows the geographic impact of Andreas Moosmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Moosmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Moosmann more than expected).

Fields of papers citing papers by Andreas Moosmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Moosmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Moosmann. The network helps show where Andreas Moosmann may publish in the future.

Co-authorship network of co-authors of Andreas Moosmann

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Moosmann. A scholar is included among the top collaborators of Andreas Moosmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Moosmann. Andreas Moosmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kehl, Victoria, Johanna Erber, Kilian Schober, et al.. (2022). CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients. PLoS ONE. 17(5). e0268530–e0268530. 20 indexed citations
2.
Leisegang, Matthias, Kerstin Dietze, Livius Penter, et al.. (2022). Rapid single-cell identification of Epstein–Barr virus-specific T-cell receptors for cellular therapy. Cytotherapy. 24(8). 818–826. 5 indexed citations
3.
Chaudhry, M. Zeeshan, Rosaely Casalegno‐Garduño, Katarzyna Sitnik, et al.. (2020). Cytomegalovirus inhibition of extrinsic apoptosis determines fitness and resistance to cytotoxic CD8 T cells. Proceedings of the National Academy of Sciences. 117(23). 12961–12968. 26 indexed citations
4.
Gary, Regina, Michael Aigner, Stefanie Schaffer, et al.. (2018). Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell grafts. Journal of Translational Medicine. 16(1). 124–124. 13 indexed citations
5.
Brandmüller, Christine, Yasemin Suezer, Asisa Volz, et al.. (2017). A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cells. Vaccine. 35(38). 5131–5139. 10 indexed citations
6.
Albanese, Manuel, Takanobu Tagawa, Mickaël Bouvet, et al.. (2016). Epstein–Barr virus microRNAs reduce immune surveillance by virus-specific CD8 + T cells. Proceedings of the National Academy of Sciences. 113(42). E6467–E6475. 127 indexed citations
7.
Tagawa, Takanobu, Manuel Albanese, Mickaël Bouvet, et al.. (2016). Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing. The Journal of Experimental Medicine. 213(10). 2065–2080. 105 indexed citations
8.
Hubmann, Max, Susanne Fritsch, Dušan Prevalšek, et al.. (2016). Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation. Journal of Clinical Virology. 82. 33–40. 21 indexed citations
9.
Tischer, Johanna, Nicole Engel, Susanne Fritsch, et al.. (2015). Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings. Annals of Hematology. 94(10). 1677–1688. 54 indexed citations
10.
Wiesner, Martina, et al.. (2015). A Diverse Repertoire of CD4 T Cells Targets the Immediate-Early 1 Protein of Human Cytomegalovirus. Frontiers in Immunology. 6. 598–598. 13 indexed citations
11.
Jochum, Simon, et al.. (2012). RNAs in Epstein–Barr virions control early steps of infection. Proceedings of the National Academy of Sciences. 109(21). E1396–404. 65 indexed citations
12.
Moosmann, Andreas, Iris Bigalke, Johanna Tischer, et al.. (2010). Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells. Blood. 115(14). 2960–2970. 173 indexed citations
13.
Seto, Eri, Andreas Moosmann, Sebastian Grömminger, et al.. (2010). Micro RNAs of Epstein-Barr Virus Promote Cell Cycle Progression and Prevent Apoptosis of Primary Human B Cells. PLoS Pathogens. 6(8). e1001063–e1001063. 183 indexed citations
14.
Weigand, Luise, Ingrid Schuster, Matthias Leisegang, et al.. (2009). A Single TCRα-Chain with Dominant Peptide Recognition in the Allorestricted HER2/neu-Specific T Cell Repertoire. The Journal of Immunology. 184(3). 1617–1629. 27 indexed citations
15.
Landmeier, Silke, Bianca Altvater, Sibylle Pscherer, et al.. (2009). Activated Human γδ T Cells as Stimulators of Specific CD8+ T-cell Responses to Subdominant Epstein Barr Virus Epitopes. Journal of Immunotherapy. 32(3). 310–321. 28 indexed citations
16.
Wiesner, Martina, et al.. (2008). Conditional Immortalization of Human B Cells by CD40 Ligation. PLoS ONE. 3(1). e1464–e1464. 79 indexed citations
17.
Kruschinski, Anna, Andreas Moosmann, Isabel Poschke, et al.. (2008). Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas. Proceedings of the National Academy of Sciences. 105(45). 17481–17486. 158 indexed citations
18.
Lang, Stephan, Sanjay Tiwari, Michaela Andratschke, et al.. (2007). Immune restoration in head and neck cancer patients after in vivo COX-2 inhibition. Cancer Immunology Immunotherapy. 56(10). 1645–1652. 20 indexed citations
19.
Adhikary, Dinesh, Uta Behrends, Andreas Moosmann, et al.. (2006). Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins. The Journal of Experimental Medicine. 203(4). 995–1006. 113 indexed citations
20.
Zeidler, Reinhard, et al.. (2006). Genetic design of an optimized packaging cell line for gene vectors transducing human B cells. Gene Therapy. 13(10). 844–856. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dai Iwakiri Breakdown of academic impact, for papers by Claire Shannon‐Lowe Breakdown of academic impact, for papers by Kathrin Zitzmann Breakdown of academic impact, for papers by Ken‐Ichi Imadome Breakdown of academic impact, for papers by Jianmin Zuo Breakdown of academic impact, for papers by Nancy Gudgeon Breakdown of academic impact, for papers by Thomas Duhen Breakdown of academic impact, for papers by Heather M. Long Breakdown of academic impact, for papers by Misako Yajima Breakdown of academic impact, for papers by Jacqueline M. Burrows
Rankless by CCL
2026